iRhythm Technologies, Inc. (NASDAQ:IRTC) Q1 2024 Earnings Conference Call August 1, 2024 4:30 PM ET

Company Participants

Stephanie Zhadkevich - Director, Investor Relations
Quentin Blackford - President and CEO
Brice Bobzien - Chief Financial Officer
Daniel Wilson - EVP of Corporate Development and Investor Relations

Conference Call Participants

Margaret Andrew - William Blair
Allen Gong - JPMorgan
Marie Thibault - BTIG LLC
David Rescott - Baird
Nathan Treybeck - Wells Fargo
Joanne Wuensch - Citigroup
Mike Polark - Wolfe Research
Ravi Misra - Truist
David Saxon - Needham & Company
Suraj Kalia - Oppenheimer

Operator

Hello all, and welcome to iRhythm Technologies Second Quarter 2024 Earnings Conference Call. My name is Lydia and I'll be your operator today. After the prepared remarks, there'll be an opportunity to ask questions. [Operator Instructions]

I'll now hand you over to Stephanie Zhadkevich, Director of Investor Relations to begin. Please go ahead when you're ready.

Stephanie Zhadkevich

Thank you all for participating in today's call. Earlier today, iRhythm released financial results for the second quarter ended June 30, 2024. Before we begin, I'd like to remind you that management will make statements during this call that include forward-looking statements within the meaning of federal securities laws pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Any statements contained in this call that are not statements of historical fact should be deemed to be forward-looking statements.

These are based upon our current estimates and various assumptions and reflect management's intentions, beliefs and expectations about future events, strategies, competition, products, operating plans and performance. These statements involve risks and uncertainties that could cause actual results or events to materially differ from those anticipated or implied by these forward-looking statements.

Accordingly, you should not place undue reliance on these statements. For a list and description of the risks and uncertainties associated with our business, please refer to the Risk Factors section of our most recent annual and quarterly reports on Form 10-K and Form 10-Q, respectively, filed with the Securities and Exchange Commission.

Also during the call, we will discuss certain financial measures that have not been prepared in accordance with US GAAP, with respect to our non-GAAP and cash-based results, including adjusted EBITDA, adjusted operating expenses, and adjusted net loss. Unless otherwise noted, all references to financial metrics are presented on a non-GAAP basis. The presentation of this additional information should not be considered in isolation of, as a substitute for, or superior to results prepared in accordance with GAAP. Please refer to the tables in our earnings release and 10-Q for reconciliation of these measures to their most directly comparable GAAP financial measures. Unless otherwise indicated, all references to financial measures in this call, other than revenue, refer to non-GAAP results.